$HMN

ZURAITIS MARITA sold $347K of HMN

ZURAITIS MARITA (President & CEO) sold 7,500 shares of HORACE MANN EDUCATORS CORP /DE/ (HMN) at $46.25 ($0.35M total) on 2026-06-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · ZURAITIS MARITA
Published Jun 4, 2026, 1:57 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 4, 2026, 2:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$HMN
Neutral
medium confidence
Mentioned
$HMN
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HMNNeutralLow
01

Why it matters

The disclosure provides new, specific datapoint on insider activity (size, price, post-sale holdings) but does not by itself indicate a change in company fundamentals, especially given the stated 10b5-1 plan.

02

Market read

Primarily a sentiment/positioning datapoint for HMN; expected to be low impact unless paired with other negative catalysts.

03

What to watch

Traders should check whether there were multiple insider transactions around the same period or any concurrent fundamental news; this article alone provides limited signal.

Relevance 6/10Novelty 6/10Timing: Filed today; sale occurred 2026-06-02 and is now disclosed.

Background

This is an SEC Form 4 insider transaction disclosure for Horace Mann Educators (HMN).

Company-level read

Ticker impact

$HMNNeutralMedium confidence
Context

Horace Mann Educators CEO Marita Zuraitis sold 7,500 HMN shares in an open-market transaction disclosed via SEC Form 4.

Expected impact

Likely minimal price impact; any reaction is typically short-lived unless accompanied by other negative fundamentals.

Evidence & confidence

The filing is a routine Form 4 open-market sale under a pre-arranged 10b5-1 plan, which reduces interpretive signal about company prospects.

Market effects

No clear sector read-through from a single 10b5-1 insider sale.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, the transaction may reflect diversification or scheduled liquidity rather than bearish expectations.

Key entities

  • Horace Mann Educators Corp /DE/

    Issuer of HMN securities; subject of the Form 4 insider sale.

  • ZURAITIS MARITA

    President & CEO who executed the open-market sale under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HMNMed

Horace Mann Educators Q2 Earnings Call Highlights

Horace Mann (NYSE:HMN) reported Q2 call highlights. Management said auto frequency and severity trends were favorable and liability losses mid-single digits. It cut its full-year catastrophe-loss assumption to about $75M from $90M, while lowering total net investment income outlook to $465M-$475M. Revenue rose 8% YoY; life sales +20%.

$HMNHigh

HORACE MANN EDUCATORS CORP /DE/ (HMN): Results of Operations and Financial Condition

HORACE MANN EDUCATORS CORP /DE/ (HMN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Glossary of Selected Terms The following measures are used by the Company’s management to evaluate financial performance against historical results and establish targets on a consolidated basis. A number of these measures are components of net income or the balance s

$HMNMedAI 8/10

Horace Mann Educators to Buy Medical Mutual Units in $240M Employer Benefits Push

Horace Mann Educators (NYSE:HMN) plans to buy units of Medical Mutual Life Group Life & Disability and other businesses in a $240M employer benefits push. Company executives said the deals add 1M+ covered lives and 7,000+ employer relationships, with limited base-case synergies. Horace Mann expects Employee Services to close in Q4 and other deals in Q1, with ~10% to 12% tangible book value dilution and a 6 to 7 year payback.